These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 33139601)

  • 41. The Human Gut Microbiome - A Potential Controller of Wellness and Disease.
    Kho ZY; Lal SK
    Front Microbiol; 2018; 9():1835. PubMed ID: 30154767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Gut microbiota and obesity: Pathogenetic relationships and ways to normalize the intestinal microflora].
    Drapkina OM; Korneeva ON
    Ter Arkh; 2016; 88(9):135-142. PubMed ID: 28635818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome: A systematic review and meta-analysis.
    Asha MZ; Khalil SFH
    Sultan Qaboos Univ Med J; 2020 Feb; 20(1):e13-e24. PubMed ID: 32190365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases.
    Quaranta G; Sanguinetti M; Masucci L
    Front Immunol; 2019; 10():2653. PubMed ID: 31827467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential role of the intestinal microbiota in programming health and disease.
    Goulet O
    Nutr Rev; 2015 Aug; 73 Suppl 1():32-40. PubMed ID: 26175488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease.
    Ghouri YA; Richards DM; Rahimi EF; Krill JT; Jelinek KA; DuPont AW
    Clin Exp Gastroenterol; 2014; 7():473-87. PubMed ID: 25525379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Intestinal microbiota - a vital "organ" with manifold functions].
    Konturek P; Konturek K; Zopf Y; Harsch IA
    MMW Fortschr Med; 2020 Mar; 162(Suppl 4):9-14. PubMed ID: 32189316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of the gut microbiome in chronic liver disease: the clinical evidence revised.
    Schwenger KJ; Clermont-Dejean N; Allard JP
    JHEP Rep; 2019 Sep; 1(3):214-226. PubMed ID: 32039372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microbiota in Pancreatic Diseases: A Review of the Literature.
    Schepis T; De Lucia SS; Nista EC; Manilla V; Pignataro G; Ojetti V; Piccioni A; Gasbarrini A; Franceschi F; Candelli M
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases.
    Konturek PC; Haziri D; Brzozowski T; Hess T; Heyman S; Kwiecien S; Konturek SJ; Koziel J
    J Physiol Pharmacol; 2015 Aug; 66(4):483-91. PubMed ID: 26348073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut microbiota and pancreatic diseases.
    Signoretti M; Roggiolani R; Stornello C; Delle Fave G; Capurso G
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):399-410. PubMed ID: 28240004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Microbiota and irritable bowel syndrome: A critical inventory].
    Enck P; Mazurak N
    Z Gastroenterol; 2019 Jul; 57(7):859-870. PubMed ID: 31288282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nutrition, gut microbiota and child health outcomes.
    Videhult FK; West CE
    Curr Opin Clin Nutr Metab Care; 2016 May; 19(3):208-13. PubMed ID: 26870888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
    Liu X; Cao S; Zhang X
    J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies.
    Rodiño-Janeiro BK; Vicario M; Alonso-Cotoner C; Pascua-García R; Santos J
    Adv Ther; 2018 Mar; 35(3):289-310. PubMed ID: 29498019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders.
    Lee HJ; Choi JK; Ryu HS; Choi CH; Kang EH; Park KS; Min YW; Hong KS
    J Neurogastroenterol Motil; 2017 Jan; 23(1):9-19. PubMed ID: 28049862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.